Status:
COMPLETED
Comparison of Insulins Aspart and Lispro in Insulin Pumps
Lead Sponsor:
Tulane University Health Sciences Center
Conditions:
Type 1 Diabetes Mellitus
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
The purpose of the study is to compare the glycemic control between insulins aspart and lispro 48 to 100 hours after pump infusion line change in subjects with type 1 using diabetes using an insulin p...
Detailed Description
Continuous subcutaneous insulin infusion (Insulin pump therapy) is a well established tool for the management of type 1 diabetes. In clinical trials, insulin pump therapy has been shown to have increa...
Eligibility Criteria
Inclusion
- Type 1 Diabetes treated with a pump for at least 3 months
Exclusion
- Pregnancy
- Plasma Creatinine \> 1.2 mg/dl
- Inability to give informed consent
- HbA1c \> 8%
- Known or suspected hypersensitivity to trial drugs or any of their components
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00461331
Start Date
October 1 2004
End Date
August 1 2008
Last Update
January 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Translational Unit - Tulane School of Medicine
New Orleans, Louisiana, United States, 70112